See analyst estimates and all valuation multiples for Drug Delivery Systems
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $22.9B | 9.5x | 40.8x | |
| $6.5B | 5.0x | 20.4x | |
| $5.8B | n/a | n/a | |
| $4.1B | 3.5x | 12.8x | |
| $3.7B | 15.4x | 41.9x | |
| $3.7B | 138.9x | -3.5x | |
| $2.3B | 46.5x | n/a | |
| $1.9B | 32.3x | -8.2x | |
| $1.2B | 14.6x | -398.6x | |
| $1.1B | n/a | n/a | |
| $1.0B | 3.3x | n/a | |
| $618M | 18.5x | -59.4x | |
| $530M | 13.5x | -3.9x | |
| $296M | 26.9x | -326.9x | |
| $282M | 3.9x | 20.3x | |
| $257M | 4.3x | -4.6x | |
| $234M | 6.0x | -10.5x | |
| $204M | n/a | n/a | |
| $191M | n/a | -6.5x | |
| $176M | 41.7x | -1.3x | |
| $168M | 8.1x | -83.4x | |
| $161M | n/a | n/a | |
| $97.4M | n/a | n/a | |
| $85.9M | n/a | n/a | |
| $80.7M | 244.2x | n/a | |
| $70.4M | 8.2x | n/a | |
| $67.9M | n/a | n/a | |
| $53.8M | 9.0x | -2.5x | |
| $42.0M | n/a | n/a | |
| $40.2M | 367.8x | n/a | |
| $37.7M | 76.9x | n/a | |
| $36.0M | 6.0x | -8.6x | |
| $34.1M | n/a | n/a | |
| $27.3M | n/a | n/a | |
| $25.2M | n/a | n/a | |
| $24.4M | 10.4x | -1.1x | |
| $22.1M | n/a | -1.5x | |
| $20.6M | 26.8x | n/a | |
| $14.0M | n/a | n/a | |
| $13.9M | n/a | n/a | |
| $11.5M | 17.4x | n/a | |
| -$1.5M | -0.3x | n/a | |
| -$12.1M | -9.7x | n/a | |
| -$98.8M | -1.0x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Drug Delivery Systems